WA Rev Code § 43.371.060 (2021)
2021 Revised Code of Washington|Title 43 - State Government—Executive|Chapter 43.371 - Statewide Health Care Claims Data.|43.371.060 - Health care data reports—Public comment period—Preparation—Contents—Publication or release of reports.

RCW 43.371.060 Health care data reports—Public comment period—Preparation—Contents—Publication or release of reports.(1)(a) Under the supervision of and through contract with the authority, the lead organization shall prepare health care data reports using the database and the statewide health performance and quality measure set. Prior to the lead organization releasing any health care data reports that use claims data, the lead organization must submit the reports to the authority for review.(b) By October 31st of each year, the lead organization shall submit to the director a list of reports it anticipates producing during the following calendar year. The director may establish a public comment period not to exceed thirty days, and shall submit the list and any comment to the appropriate committees of the legislature for review.(2)(a) Health care data reports that use claims data prepared by the lead organization for the legislature and the public should promote awareness and transparency in the health care market by reporting on:(i) Whether providers and health systems deliver efficient, high quality care; and(ii) Geographic and other variations in medical care and costs as demonstrated by data available to the lead organization.(b) Measures in the health care data reports should be stratified by demography, income, language, health status, and geography when feasible with available data to identify disparities in care and successful efforts to reduce disparities.(c) Comparisons of costs among providers and health care systems must account for differences in the case mix and severity of illness of patients and populations, as appropriate and feasible, and must take into consideration the cost impact of subsidization for uninsured and government-sponsored patients, as well as teaching expenses, when feasible with available data.(3) The lead organization may not publish any data or health care data reports that:(a) Directly or indirectly identify individual patients;(b) Disclose a carrier's proprietary financial information;(c) Compare performance in a report generated for the general public that includes any provider in a practice with fewer than four providers; or(d) Contain medicaid data that is in direct conflict with the biannual medicaid forecast.(4) The lead organization may not release a report that compares and identifies providers, hospitals, or data suppliers unless:(a) It allows the data supplier, the hospital, or the provider to verify the accuracy of the information submitted to the data vendor, comment on the reasonableness of conclusions reached, and submit to the lead organization and data vendor any corrections of errors with supporting evidence and comments within thirty days of receipt of the report;(b) It corrects data found to be in error within a reasonable amount of time; and(c) The report otherwise complies with this chapter.(5) The authority and the lead organization may use claims data to identify and make available information on payers, providers, and facilities, but may not use claims data to recommend or incentivize direct contracting between providers and employers.(6) The lead organization shall make information about claims data related to the provision of air ambulance service available on a website that is accessible to the public in a searchable format by geographic region, provider, and other relevant information.(7)(a) The lead organization shall distinguish in advance to the authority when it is operating in its capacity as the lead organization and when it is operating in its capacity as a private entity. Where the lead organization acts in its capacity as a private entity, it may only access data pursuant to RCW 43.371.050(4) (b), (c), or (d).(b) Except as provided in RCW 43.371.050(4), claims or other data that contain direct patient identifiers or proprietary financial information must remain exclusively in the custody of the data vendor and may not be accessed by the lead organization.[ 2020 c 131 § 1; 2019 c 319 § 6; 2015 c 246 § 6; 2014 c 223 § 14.]NOTES:Effective date—2019 c 319: See note following RCW 43.371.020.Finding—2014 c 223: See note following RCW 41.05.690.